Search Results (1,757)

We propose a theoretical framework based on an affine-eigenstate transformation for analyzing ultracold atom–molecule conversion dynamics with particle loss. The transformation maps the mean-field dynamics to an effective two-mode representation in which fixed points, Bloch-sphere trajectories, and linear stability can be examined in a common set of variables. We give the derivation of the transformed Hamiltonian and specify the invertibility and conjugate-condition requirements under which the mapping is used. Within this representation, we distinguish ordinary, pseudo, and strict self-trapping regimes. The strict regime is associated with the balanced condition $S=0$ in the transformed variables; in the corresponding linearized dissipative flow, the leading attractor/repeller bifurcation term controlled by $S{\mathsf{\Gamma }}_{-}$ vanishes, explaining the observed robustness against atom- and molecule-loss imbalance. We also introduce von Neumann and linear-entropy diagnostics for future mixed-state or ensemble descriptions in the transformed two-level representation, and we provide an inverse reconstruction procedure for preparing initial states that realize strict self-trapping. Finally, we discuss the limits of the mean-field and Markovian approximations and outline how finite-particle simulations and phase-modulated control protocols could connect this mechanism to decoherence-resilient quantum simulations and information-processing architectures. Full article

Protein-based biosensors require controlled and site-selective functionalization strategies to enable stable and oriented immobilization without compromising protein structure and signal transduction efficiency. We evaluated a chemoselective linchpin-directed modification (LDM) approach targeting Lys–His pairs as a tool for site-specific labeling of the model fluorescent biosensor green fluorescent protein (GFP). LDM molecules with variable spacer lengths were prepared, and a structure-guided computational workflow was implemented to map Lys–His distances on the protein and identify candidate modification sites. Experimental validation by UV-Vis spectroscopy and mass spectrometry demonstrated efficient conjugation and a final degree of labeling close to unity, consistent with single-site modification, with all LDM molecules selectively targeting the same histidine residue (His181), independently of spacer length. Structural analysis revealed that this residue is located within an accessible internal cavity that favors productive interactions with the reactive group. Importantly, the modification preserves GFP fluorescence and pH response, confirming retention of sensing functionality. These results demonstrate that LDM enables selective modification not only of surface residues, but also of structurally guided, non-surface residues. This approach provides the proof of concept of a new, promising strategy for the controlled functionalization and immobilization of protein-based biosensors. Full article

Crimean–Congo hemorrhagic fever virus (CCHFV) remains a major public health threat due to its high mortality rates and the absence of approved antiviral therapies. The viral ovarian tumor (OTU) protease is a critical virulence factor that suppresses host innate immunity through its deubiquitinase activity, making it an attractive therapeutic target. In this study, we employed a structure-guided approach to identify and validate novel small-molecule inhibitors targeting the non-catalytic Y89-W99 pocket of the OTU protease. Recombinant OTU protease was successfully expressed, purified, and refolded, yielding a soluble and enzymatically active protein. Cellular assays confirmed that the enzyme retains robust deubiquitinase activity, significantly reducing global ubiquitin conjugates in mammalian cells. In silico analysis of a putative DUB inhibitor library identified several candidate inhibitors with favorable binding interactions within the Y89-W99 pocket. Biochemical validation using a fluorometric Ub-AMC assay revealed that multiple small molecules strongly inhibit OTU activity, including OTUi-10 (~93% inhibition), OTUi-13 (~87%), OTUi-1 (~85%), OTUi-4 and OTUi-11 (~81%), and OTUi-9 (~76%). Additional moderate inhibitors included OTUi-12 (~67%), OTUi-19 and OTUi-21 (~66%), and OTUi-5 (~57%). In silico drug-likeness and toxicity profiling filtered the library to four fully compliant candidates, OTUi-4, OTUi-10, OTUi-11, and OTUi-12, all free of predicted toxicity alerts. These findings suggest that the Y89–W99 pocket may be a pharmacologically relevant site worthy of further investigation and identify OTUi-10, OTUi-4, and OTUi-11 as promising preliminary hit compounds. The results also provide initial insights that may guide future optimization and mechanistic studies of OTU protease inhibitors targeting CCHFV. Full article

Renal cell carcinoma (RCC) is a biologically heterogeneous malignancy characterized by variable clinical behavior and diverse molecular phenotypes. Although immune checkpoint inhibitors and targeted therapies have transformed the treatment landscape of advanced RCC, clinically validated biomarkers capable of improving risk stratification, therapeutic-decision making and disease monitoring remain lacking. Kidney injury molecule-1 (KIM-1), also known as hepatitis A virus cellular receptor-1 (HAVCR1) or T-cell immunoglobulin and mucin domain-containing protein-1 (TIM-1), has emerged as a biologically compelling investigational biomarker e because of its close relationship to proximal tubular epithelial injury and renal carcinogenesis. KIM-1 is a transmembrane glycoprotein minimally expressed in normal kidney tissue but markedly upregulated in dedifferentiated proximal tubular epithelial cells following injury, and in clear cell RCC, where its extracellular domain can be shed into plasma and urine. Beyond its role as a marker of tubular injury, KIM-1 participates in immune regulation, phagocytosis, inflammatory signaling and tissue remodeling, supporting its potential relevance to tumor biology. Clinical studies have demonstrated associations between elevated circulating KIM-1 levels and RCC diagnosis, recurrence risk, and survival outcomes, particularly in localized and postoperative disease settings. KIM-1 has additionally been investigated as a therapeutic target through antibody–drug conjugate approaches. Despite promising translational data, important limitations yet remain. Current evidence is predominantly prognostic rather than predictive, and substantial analytical and biological challenges continue to limit implementation. Assay standardization, clinically meaningful cutoffs, specimen selection, timing of sampling, and confounding by chronic kidney disease or nonmalignant renal injury remain incompletely resolved. Furthermore, evidence supporting incremental value beyond established clinicopathologic models remains limited. This review critically evaluates the biological rationale, analytical considerations and clinical evidence supporting KIM-1 in RCC. Particular emphasis is placed on distinguishing prognostic, predictive, pharmacodynamic, and therapeutic applications, as well as defining the evidentiary gaps that must be addressed before clinical implementation. Current evidence is derived predominantly from retrospective and exploratory analyses, and important limitations remain regarding assay standardization, biological specificity, chronic kidney disease-related confounding, and prospective validation. The review concludes with a summary of the evolving landscape of KIM-1-directed biomarker strategies in RCC, which may ultimately contribute to improved biologic risk stratification and biomarker-driven clinical investigation in RCC. Full article

Single-molecular white circularly polarized luminescence emitters show promise for use in chiral displays and solid-state lighting, but their design remains challenging because broadband emission, exciton utilization, color balance, and chiroptical activity must be integrated within one molecule. Herein, we report a chiral single-molecular white emitter, DCz-PTZ, constructed through a π-interrupted strategy by combining a rigid spiro framework, an oxygen-bridged carbazole/cyanobenzene segment, and a phenothiazine donor. The interrupted conjugation suppresses excessive charge-transfer (CT) domination and enables dual emissive channels, including short-wavelength locally excited (LE) emission and long-wavelength CT emission. DCz-PTZ exhibits near-ideal white emission in dilute toluene solution with CIE coordinates of (0.33, 0.33), and maintains balanced dual emission in 5 wt% doped films with CIE coordinates of (0.32, 0.34). Photophysical studies support the assignment of the yellow emission to a thermally activated delayed fluorescence (TADF)-active CT state. The enantiomers show mirror-image circularly polarized signals with |g_lum| up to 2.9 × 10⁻³. Optimized white organic light-emitting diodes (WOLEDs) achieve color rendering index (CRI) up to 92 and a maximum external quantum efficiency (EQE_max) of 1.3%. This work demonstrates a π-interrupted molecular strategy for integrating dual emission, TADF exciton utilization, and circularly polarized electroluminescence (CPEL) in a single chiral emitter. Full article

Light-triggered hydrogel systems offer precise spatiotemporal control over drug release, yet most existing approaches require direct chemical conjugation of a photocleavable linker to the payload, which risks compromising bioactivity and limits applicability to structurally diverse molecules. Here, we report a gelatin–poly(ethylene glycol) (PEG) hybrid hydrogel crosslinked via strain-promoted azide–alkyne cycloaddition (SPAAC) click chemistry, in which an o-nitrobenzyl photocleavable (PC) linker is incorporated into the PEG crosslinker arm rather than conjugated to the drug. Acetylated gelatin–azide (AGA) was synthesized by sequential azide functionalization and amine capping of gelatin, and four-arm PEG-PC-DBCO (4armPEG-PC-DBCO) was prepared by coupling a PC DBCO-PEG4-NHS ester to four-arm PEG amine. Successful incorporation of the azide, DBCO, and o-nitrobenzyl moieties was confirmed by FT-IR spectroscopy, ¹H NMR spectroscopy, and UV-Vis spectrophotometry. Hydrogel formation under physiological conditions (PBS, 37 °C) without catalysts or initiators was verified by rheological frequency sweep analysis, which confirmed elastic-dominant behavior (G′ > G″). Upon irradiation at 365 nm, the crosslinker was cleaved, and rapid network dissolution was observed both macroscopically and by in situ time sweep rheology. This platform enables on-demand, UV-selective hydrogel degradation independently of payload identity, providing a versatile foundation for future controlled drug release applications and dynamic, on-demand degradable scaffolds for tissue engineering. Full article

Radiometabolic therapy is a mechanistically plausible but clinically underused strategy in lymphoma. Its rationale is based on the selective delivery of cytotoxic radiation to malignant lymphoid cells through antibodies, peptides, or small molecules directed against tumor-associated targets. Radioimmunotherapy with anti-CD20 agents, including 90Y-ibritumomab tiuxetan and 131I-tositumomab, demonstrated meaningful efficacy in B-cell non-Hodgkin lymphoma, particularly in indolent and relapsed/refractory settings. However, despite encouraging clinical results, its use progressively declined because of logistical, regulatory, commercial, and multidisciplinary barriers. More recently, renewed interest has emerged with the development of novel antibody–radionuclide conjugates and radioligand-based theranostic strategies targeting CD22, CD37, CD45, and CXCR4. Among these, CXCR4-directed imaging and therapy with 68Ga-pentixafor and 177Lu/90Y-pentixather illustrate image-guided patient selection and targeted radionuclide treatment in advanced hematologic malignancies. This narrative review summarizes evidence retrieved from Scopus and PubMed on radiometabolic therapy in lymphoma, with particular attention paid to established radioimmunotherapy, emerging targets, radioligand therapy, dosimetry, toxicity, and combination strategies with chemotherapy, immunotherapy, and hematopoietic stem cell transplantation. Available evidence supports the plausibility and possible clinical utility of these approaches, but remains heterogeneous and, for several newer targets, preliminary. Future development will require prospective trials, standardized imaging-based selection, individualized dosimetry, and integration within multidisciplinary lymphoma treatment pathways. Full article

Bile acids (BA) are increasingly recognized as signaling molecules involved in metabolic regulation and inflammatory processes, both of which are relevant to Parkinson’s disease (PD). However, their role in PD and disease progression remains unclear. In this study, plasma BA profiles were analyzed in 113 participants, including early- and advanced-stage PD patients and age- and sex-matched controls, across three time points over three years. Targeted metabolomics using LC-MS was applied to quantify 20 BA, complemented by analyses of functional ratios, including unconjugated/conjugated and hydrophobic/hydrophilic BA ratios and correlation patterns between BA species. Although most individual BA did not show consistent longitudinal changes, pooled analysis identified significant differences in the unconjugated/conjugated BA ratio between PD patients and controls. In contrast, the hydrophobic/hydrophilic ratio did not differ significantly between groups. Correlation analysis revealed differences in selected BA interrelationships, particularly involving primary and secondary BA, while the overall network structure remained largely preserved. These results indicate that BA metabolism in PD might be characterized rather by subtle, distributed alterations than pronounced changes in individual metabolites. BA profiling may therefore contribute to a broader metabolic characterization of PD, but its utility as a standalone biomarker appears limited. Full article

Background/Objectives: Antimicrobial resistance and bacterial persistence underscore the need to develop new chemotypes with multifunctional antibacterial mechanisms. This study aimed to design, synthesize, and evaluate curcumin-inspired 3,5-diarylidene-4-piperidones as versatile small molecules exhibiting antibacterial, antibiofilm, anti-efflux, DNA gyrase-inhibitory, and antiproliferative properties. Methods: A targeted series of triazole-conjugated 3,5-diarylidene-4-piperidones was synthesized through copper-catalyzed azide-alkyne cycloaddition click chemistry and subsequently characterized using standard spectroscopic techniques. The compounds were assessed for antibacterial activity against Staphylococcus aureus, Enterococcus faecalis, and Escherichia coli. Selected active compounds underwent further evaluation for DNA gyrase inhibition, antibiofilm activity against multidrug-resistant S. aureus ATCC 33591, ethidium bromide accumulation, and antiproliferative effects on HCT116 and MCF7 cancer cells, with RPE1 cells serving as a control to evaluate cytotoxicity in normal cells. Additionally, computational studies, including QSAR analysis and molecular docking, were conducted to bolster structure–activity relationships and provide mechanistic insights. Results: Several derivatives demonstrated selective antibacterial activity against Gram-positive bacteria, particularly S. aureus, while exhibiting limited or no efficacy against E. coli. Compounds 7n and 7l emerged as the most potent against S. aureus, with minimum inhibitory concentrations (MICs) of 7.8 and 8.2 μM, respectively. Notably, compound 7l inhibited S. aureus DNA gyrase supercoiling, displaying an IC₅₀ of 3.20 μM, comparable to ciprofloxacin. Compound 7e exhibited the strongest antibiofilm activity against multidrug-resistant S. aureus, whereas compound 7a resulted in the highest accumulation of ethidium bromide, indicating robust anti-efflux activity. Antiproliferative assays revealed that select halogenated derivatives were effective against HCT116 and MCF7 cells, while the most promising antibacterial compounds exhibited minimal cytotoxicity toward RPE1 cells. Quantitative structure–activity relationship (QSAR) and docking studies supported the observed structure–activity relationships and suggested potential interactions with the ATPase binding site of DNA gyrase B. Conclusions: Triazole-conjugated 3,5-diarylidene-4-piperidones are promising multifunctional scaffolds with selective anti-S. aureus activity, antibiofilm and anti-efflux properties, and, for compound 7l, potent DNA gyrase inhibition. These findings support further optimization of this chemotype as a platform for developing antibacterial agents with polymechanistic activity. Full article

Triple-negative breast cancer (TNBC), characterized by the lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2) expression, is a highly aggressive molecular subtype with high recurrence and metastasis rates. Due to the absence of reliable molecular targets, surgery combined with chemotherapy remains the mainstay of clinical treatment. In recent years, immunotherapy has provided new strategies for TNBC management. Immune checkpoints are key regulatory molecules that maintain immune homeostasis, and blocking these checkpoints can restore T cell activity and enhance tumor cell killing. Immune checkpoint inhibitors (ICIs) have demonstrated clinical benefit, particularly in combination with chemotherapy for patients with locally advanced or metastatic TNBC. This review focuses on immune checkpoint–based immunotherapy in TNBC, providing an overview from mechanistic insights to clinical applications and emerging therapeutic strategies. In addition to ICIs, we discuss alternative approaches, such as bispecific antibodies, antibody–drug conjugates (ADCs), chimeric antigen receptor T cell (CAR-T) therapy, tumor vaccines, and oncolytic viruses (OVs), highlighting their current research progress and clinical applications in TNBC treatment. Full article

Annulated organic molecular structures with planar, fused backbones exhibit superior properties compared to non-fused systems, including high crystallinity, strong π–π stacking, and excellent charge transport characteristics. The rational design of annulated compounds with targeted characteristics presents a significant challenge that requires a comprehensive understanding of structure–property relationships. This work addresses this by synthesizing a series of novel push–pull systems featuring benzothieno[3,2-b]benzothiophene (BT) or its nitrogen-rich analogue, indolo[3,2-b]indole (ID), as electron-donating units, connected via a phenylene π-spacer to two distinct electron-accepting groups (carbonyl or dicyanovinyl). The thermal, structural, optical and electrochemical properties of these compounds were thoroughly investigated. Computational studies of the optical and electrochemical properties, including those of unsubstituted ID and BT model cores, showed excellent agreement with experimental data, validating the theoretical models. Notably, ID-based derivatives exhibited remarkably high photoluminescence quantum yield and enhanced solubility compared to their BT counterparts, along with thermal properties that are more favorable for device fabrication. This work provides the first systematic comparison of these annulated cores, offering novel structure–property insights that may support the rational design of organic functional materials and contribute to the further development of organic electronics. Full article

The purpose of this study was to investigate the effectiveness and mechanism of iron-based catalysts in the treatment of phenolic wastewater by catalyzing ozone oxidation. The removal rates of phenolics and COD were systematically examined using simulation experiments with water and actual wastewater, which involved analyzing the effects of reaction time, pH, ozone dosage, catalyst dosage, and initial concentration. The phenol and COD removal rates in the simulated wastewater were 95.9% and 93.5%, respectively, respectively, while the ozone dosage was 16 mg/L/min, pH was 6.7–6.8, and catalyst dosage was 0.3 g/L. The phenol and COD removal rates in the actual wastewater were 68.6% and 68.0%, respectively. The reaction time was 30 min. The system’s efficient removal ability for phenolic compounds, polycyclic aromatic hydrocarbons, and others was confirmed through three-dimensional fluorescence and ultraviolet spectroscopy. The iron-based catalyst generates ·OH through three pathways: adsorption of activated ozone on surface active sites, continuous production of free radicals by Fe²⁺/Fe³⁺ cycling, and direct activation of ozone by Fe²⁺. This mechanism analysis showed that the catalyst generates ·OH. These pathways convert pollutants into small molecules or mineralized by attacking the aromatic rings and conjugated structures of pollutants. Technical references for the deep treatment of phenol-containing wastewater are provided in this study. Full article

Porcine blood meal-derived hydrolysate peptides and hemin are natural antioxidants, and the formation of peptide–hemin conjugates can synergistically improve antioxidant performance. Ultrasonic (US) treatment facilitates the binding of different molecules. Therefore, in this study, the effects of ultrasonic power treatments on the antioxidant activity and binding behavior of peptide–hemin conjugates were investigated. The spatial structure of the peptide–hemin conjugates was characterized using endogenous fluorescence spectroscopy, Fourier transform infrared (FT-IR) spectroscopy, and circular dichroism (CD) spectroscopy, respectively. The results demonstrated that the peptide–hemin binding rate reached the highest value of 91.63% at 400 W US power, with structural changes in conjugates from α-helix to random coil structures. Additionally, US treatment increased the surface hydrophobicity and reduced the enthalpy change in conjugates. The antioxidant capacity was greatly improved and peaked at 400 W US, where DPPH and ABTS radical scavenging rates exceeded 55% and 65%, respectively. This study provided a scientific basis for the high-value utilization of US treatment on porcine blood meal resources. Full article

The color origin of precious coral, a highly valued biogenic polycrystalline gemstone, has long remained elusive. In this study, an integrated approach employing spectrophotometry, Raman, FTIR, and UV-Vis spectroscopy, coupled with Spearman correlation analysis, was utilized to investigate a color-graded series of precious coral samples ranging from white to red. The results demonstrate that the calcareous composition of the samples tested in our study consists exclusively of calcite. The actual chromophores are identified as a blend of multiple distinct polyene species, characterized by Raman shifts at 1126 and 1515 cm⁻¹, with density functional theory (DFT) calculations determining the number of conjugated (C=C) bonds in the polyene chain to be 10–11. Inherently exhibiting a red-orange hue, the progressive accumulation of these polyenes drives a systematic color transition from orange to red. Both absorption bands at 314 nm and 532 nm in the UV-Vis spectra are attributed to the polyene pigment molecules. Specifically, the broad 532 nm band is dominated by π-π* electronic transitions, while the 314 nm band likely arises from terminal benzene rings and their derivatives. As the pigment concentration increases, this band exhibits pronounced broadening and an increase in absorbance, accompanied by a redshift in the maximum absorption peak. This spectral evolution leads to an intensified absorption in the yellow-orange region, elucidating the intrinsic mechanism underlying the color transition of precious coral from orange to red with increasing pigment content. This work lays a solid foundation for the non-destructive identification of precious corals and future research on their color genesis. Full article

Background/Objectives: Colistin (COL), administered as a prodrug colistimethate sodium (CMS), is commonly used to treat infections caused by multidrug-resistant Gram-negative bacteria in critically ill patients. Given high CMS instability, very complex and variable pharmacokinetics (PK) and high incidence of toxicity, therapeutic drug monitoring (TDM) of active COL might play an important role. This study aimed to develop and validate an accessible immunoassay-based approach for COL monitoring in human serum. Methods: A direct competitive enzyme-linked immunosorbent assay (dcELISA) was developed using polyclonal (pAb) anti-polymyxin antibody alongside a polymyxin B–horseradish peroxidase conjugate. CMS conversion to COL along with serum deproteinization was achieved using 5% trichloroacetic acid (TCA) treatment at 37 °C. Assay accuracy and precision were assessed by spike-and-recovery experiments in healthy volunteer serum. The assay was applied to serum samples from critically ill patients with burns or pneumonia receiving CMS therapy. The reliability of the measurements was confirmed by parallel dcELISA based on a reference monoclonal antibody (mAb) against fragmented polymyxin molecule. Results: Both ELISA formats demonstrated high sensitivity, with limits of detection of 0.053 ng/mL (pAb) and 0.047 ng/mL (mAb). TCA treatment achieved maximal CMS hydrolysis under tested conditions within one hour. Clinical sample analysis showed excellent agreement between the two assays (R² = 0.996), with Bland–Altman analysis revealing a minimal bias of 3.7%. Exploratory PK analysis in burn patients demonstrated increased total drug volume of distribution (45.7–64.9 L) and clearance (8.3–16.3 L/h). Conclusions: This is the first report of ELISA for COL TDM in critically ill patients. The method offers acceptable analytical performance and practical simplicity, with potential to broaden TDM access beyond specialist centers. Full article